Primary somatosensory cortex in chronic low back pain - A 1H-MRS study

Journal of Pain Research

Volumn 4, Issue , 2011, Pages 143-150

  Sharma, Neena K ^a   McCarson, Kenneth ^b   Van Dillen, Linda ^c   Lentz, Angela ^a   Khan, Talal ^b   Cirstea, Carmen M ^a  

^a UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic low back pain; Magnetic resonance spectroscopy; Neuronal glial interactions; Primary somatosensory cortex

Indexed keywords

EID: 84861893650     PISSN: 11787090     EISSN: None     Source Type: Journal    
DOI: 10.2147/JPR.S19297     Document Type: Article

References (38)

1. Andersson GB. Epidemiological features of chronic low-back pain. Lancet. 1999;354(9178):581-585.
2. Ritzwoller DP, Crounse L, Shetterly S, Rublee D. The association of comorbidities, utilization and costs for patients identified with low back pain. BMC Musculoskelet Disord. 2006;7:72.
3. Wasiak R, Kim J, Pransky G. Work disability and costs caused by recurrence of low back pain: longer and more costly than in first episodes. Spine (Phila Pa 1976). 2006;31(2):219-225.
4. Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299(6): 656-664.
5. Jensen MC, Brant-Zawadzki MN, Obuchowski N, Modic MT, Malkasian D, Ross JS. Magnetic resonance imaging of the lumbar spine in people without back pain. N Engl J Med. 1994;331(2):69-73.
6. Giesecke T, Gracely RH, Grant MA, et al. Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum. 2004;50(2):613-623.
7. Grachev ID, Ramachandran TS, Thomas PS, Szeverenyi NM, Fredrickson BE. Association between dorsolateral prefrontal n-acetyl aspartate and depression in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. J Neural Transm. 2003;110(3): 287-312.
8. Grachev ID, Fredrickson BE, Apkarian AV. Brain chemistry reflects dual states of pain and anxiety in chronic low back pain. J Neural Transm. 2002;109(10):1309-1334.
9. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89(1):7-18.
10. Gussew A, Rzanny R, Gullmar D, Scholle HC, Reichenbach JR. 1h-mr spectroscopic detection of metabolic changes in pain processing brain regions in the presence of non-specific chronic low back pain. Neuroimage. 2010;54(2):1315-1323.
11. Wrigley PJ, Press SR, Gustin SM, et al. Neuropathic pain and primary somatosensory cortex reorganization following spinal cord injury. Pain. 2009;141(1-2):52-59.
12. Henderson LA, Gustin SM, Macey PM, Wrigley PJ, Siddall PJ. Functional reorganization of the brain in humans following spinal cord injury: evidence for underlying changes in cortical anatomy. J Neurosci. 2011;31(7):2630-2637.
13. Sharma NK, Ryals JM, Liu H, Liu W, Wright DE. Acidic saline-induced primary and secondary mechanical hyperalgesia in mice. J Pain. 2009;10(12):1231-1241.
14. Cui JG, O'Connor WT, Ungerstedt U, Linderoth B, Meyerson BA. Spinal cord stimulation attenuates augmented dorsal horn release of excitatory amino acids in mononeuropathy via a gabaergic mechanism. Pain. 1997;73(1):87-95.
15. Bement MK, Sluka KA. Co-localization of p-creb and p-nr1 in spinothalamic neurons in a chronic muscle pain model. Neurosci Lett. 2007;418(1):22-27.
16. Tillu DV, Gebhart GF, Sluka KA. Descending facilitatory pathways from the rvm initiate and maintain bilateral hyperalgesia after muscle insult. Pain. 2008;136(3):331-339.
17. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000;13(3):129-153.
18. Siegel GJB, Agranoff BW, Albers GW, Fisher SK, Uhler MD. Basic Neurochemistry: Molecular, Cellular and Medical Aspects. Oxford, UK: Academic Press; 2005.
19. Flor H, Braun C, Elbert T, Birbaumer N. Extensive reorganization of primary somatosensory cortex in chronic back pain patients. Neurosci Lett. 1997;224(1):5-8.
20. Lloyd D, Findlay G, Roberts N, Nurmikko T. Differences in low back pain behavior are reflected in the cerebral response to tactile stimulation of the lower back. Spine (Phila Pa 1976). 2008;33(12): 1372-1377.
21. Schmidt-Wilcke T, Leinisch E, Ganssbauer S, et al. Affective components and intensity of pain correlate with structural differences in gray matter in chronic back pain patients. Pain. 2006;125(1-2):89-97.
22. Melzack R. The short-form McGill pain questionnaire. Pain. 1987;30(2): 191-197.
23. Zinke JL, Lam CS, Harden RN, Fogg L. Examining the cross-cultural validity of the English short-form McGill pain questionnaire using the matched moderated regression methodology. Clin J Pain. 2010; 26(2):153-162.
24. Waddell G, Newton M, Henderson I, Somerville D, Main CJ. A fearavoidance beliefs questionnaire (FABQ) and the role of fear-avoidance beliefs in chronic low back pain and disability. Pain. 1993;52(2): 157-168.
25. Beck AT, Steer RA. Internal consistencies of the original and revised Beck depression inventory. J Clin Psychol. 1984;40(6):1365-1367.
26. Cirstea MC, Brooks WM, Craciunas SC, et al. Primary motor cortex in stroke-a functional MRI-guided proton MR spectroscopic study. Stroke. 2011;42(4):1004-1009.
27. Constable RT, Skudlarski P, Mencl E, et al. Quantifying and comparing region-of-interest activation patterns in functional brain MR imaging: methodology considerations. Magn Reson Imaging. 1998;16(3): 289-300.
28. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. 1993;30(6): 672-679.
29. Moseley GL. Widespread brain activity during an abdominal task markedly reduced after pain physiology education: FMRI evaluation of a single patient with chronic low back pain. Aust J Physiother. 2005; 51(1):49-52.
30. Fukui S, Matsuno M, Inubushi T, Nosaka S. N-acetylaspartate concentrations in the thalami of neuropathic pain patients and healthy comparison subjects measured with (1)H-MRS. Magn Reson Imaging. 2006;24(1):75-79.
31. Pattany PM, Yezierski RP, Widerstrom-Noga EG, et al. Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury. AJNR Am J Neuroradiol. 2002;23(6):901-905.
32. Fayed N, Garcia-Campayo J, Magallon R, et al. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and n-acetylaspartate. Arthritis Res Ther. 2010;12(4):R134.
33. Wood PB, Ledbetter CR, Glabus MF, Broadwell LK, Patterson JC 2nd. Hippocampal metabolite abnormalities in fibromyalgia: correlation with clinical features. J Pain. 2009;10(1):47-52.
34. Bosman DK, Deutz NE, De Graaf AA, et al. Changes in brain metabolism during hyperammonemia and acute liver failure: results of a comparative 1H-NMR spectroscopy and biochemical investigation. Hepatology. 1990;12(2):281-290.
35. Heilig CW, Stromski ME, Blumenfeld JD, Lee JP, Gullans SR. Characterization of the major brain osmolytes that accumulate in saltloaded rats. Am J Physiol. 1989;257(6 Pt 2):F1108-F1116.
36. Li Z, Vance DE. Phosphatidylcholine and choline homeostasis. J Lipid Res. 2008;49(6):1187-1194.
37. Laakso MP, Hiltunen Y, Kononen M, et al. Decreased brain creatine levels in elderly apolipoprotein e epsilon 4 carriers. J Neural Transm. 2003;110(3):267-275.
38. Harris RE, Sundgren PC, Craig AD, et al. Elevated insular glutamate in fibromyalgia is associated with experimental pain. Arthritis Rheum. 2009;60(10):3146-3152.